ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Clinical trials for ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat esophageal cancer?
Disease control Not yet recruitingThis study aims to see if a new two-drug combination (anlotinib + benmelstobart) works better than the current standard treatment (toripalimab + chemotherapy) for people with advanced esophageal cancer that has specific gene changes. It will involve about 578 adults who have not …
Matched conditions: ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE3 • Sponsor: The First Affiliated Hospital of Zhengzhou University • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New drug combo trial offers hope for Tough-to-Treat esophageal cancer
Disease control Not yet recruitingThis study aims to test the safety and early effectiveness of a new combination therapy called JS212 for adults with advanced esophageal cancer that has spread or returned. It will involve about 280 patients who have not received prior drug treatment for their advanced disease. T…
Matched conditions: ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Shanghai Junshi Bioscience Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC